188 related articles for article (PubMed ID: 26599011)
1. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
He YF; Wang CQ; Yu Y; Qian J; Song K; Sun QM; Zhou J
PLoS One; 2015; 10(11):e0143657. PubMed ID: 26599011
[TBL] [Abstract][Full Text] [Related]
2. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
[TBL] [Abstract][Full Text] [Related]
3. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Englisch JP; Wiltberger G; Schierle K; Robson SC; Reutzel-Selke A; Jonas S; Pascher A; Pratschke J; Schmelzle M
J Surg Oncol; 2016 Jul; 114(1):91-8. PubMed ID: 27111031
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
World J Surg Oncol; 2019 Dec; 17(1):217. PubMed ID: 31830991
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE
Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679
[TBL] [Abstract][Full Text] [Related]
8. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
Zhang ZL; Liu ZS; Sun Q
World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
[TBL] [Abstract][Full Text] [Related]
10. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
Cortes-Santiago N; Hossain MB; Gabrusiewicz K; Fan X; Gumin J; Marini FC; Alonso MM; Lang F; Yung WK; Fueyo J; Gomez-Manzano C
Oncotarget; 2016 Mar; 7(13):16146-57. PubMed ID: 26910374
[TBL] [Abstract][Full Text] [Related]
11. Tie2-expressing monocytes as a novel angiogenesis-related cellular biomarker for non-small cell lung cancer.
Xue R; Sheng Y; Duan X; Yang Y; Ma S; Xu J; Wei N; Shang X; Li F; Wan J; Qin Z
Int J Cancer; 2021 Mar; 148(6):1519-1528. PubMed ID: 33152113
[TBL] [Abstract][Full Text] [Related]
12. The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.
Vanderborght B; Lefere S; Vlierberghe HV; Devisscher L
Cells; 2020 Oct; 9(11):. PubMed ID: 33143149
[TBL] [Abstract][Full Text] [Related]
13. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.
Venneri MA; De Palma M; Ponzoni M; Pucci F; Scielzo C; Zonari E; Mazzieri R; Doglioni C; Naldini L
Blood; 2007 Jun; 109(12):5276-85. PubMed ID: 17327411
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C.
Rodríguez-Muñoz Y; Martín-Vílchez S; López-Rodríguez R; Hernández-Bartolomé A; Trapero-Marugán M; Borque MJ; Moreno-Otero R; Sanz-Cameno P
Aliment Pharmacol Ther; 2011 Oct; 34(8):960-71. PubMed ID: 21848603
[TBL] [Abstract][Full Text] [Related]
15. Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
Ann Transplant; 2020 Mar; 25():e919414. PubMed ID: 32165607
[TBL] [Abstract][Full Text] [Related]
16. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
[TBL] [Abstract][Full Text] [Related]
18. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
19. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]